People: DelMar Pharmaceuticals Inc (DMPI.OQ)

DMPI.OQ on NASDAQ Stock Exchange Capital Market

21 Oct 2019
Change (% chg)

$0.00 (+1.01%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Praill, Scott 

Mr. Scott Praill, CPA, BSc is Chief Financial Officer of the Company. He has been our Chief Financial Officer since January 29, 2013 and previously served as a consultant to Del Mar Pharmaceuticals (BC) Ltd. From 2004 to January 2013, Mr. Praill was an independent consultant providing accounting and administrative services to companies in the resource industry. Mr. Praill served as CFO of Strata Oil & Gas, Inc. from June 2007 to September 2008. From November 1999 to October 2003, Mr. Praill was Director of Finance at Inflazyme Pharmaceuticals Ltd. Mr. Praill completed his articling at Price Waterhouse (now PricewaterhouseCoopers LLP) and obtained his Chartered Professional Accountant designation in 1996. Mr. Praill obtained his Certified Public Accountant (Illinois) designation in 2001. Mr. Praill received a Financial Management Diploma (Honors), from the British Columbia Institute of Technology in 1993, and a Bachelor of Science from Simon Fraser University in 1989.

Basic Compensation

Total Annual Compensation, USD 280,000
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 99,596
Fiscal Year Total, USD 379,596

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --